AR201880A1 - Procedimiento para la preparacion de nuevos derivados de 2-benzamido-5-nitrotiazol - Google Patents
Procedimiento para la preparacion de nuevos derivados de 2-benzamido-5-nitrotiazolInfo
- Publication number
- AR201880A1 AR201880A1 AR255045A AR25504574A AR201880A1 AR 201880 A1 AR201880 A1 AR 201880A1 AR 255045 A AR255045 A AR 255045A AR 25504574 A AR25504574 A AR 25504574A AR 201880 A1 AR201880 A1 AR 201880A1
- Authority
- AR
- Argentina
- Prior art keywords
- nitrotiazol
- benzamido
- procedure
- preparation
- new derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/58—Nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3760873A GB1437800A (en) | 1973-08-08 | 1973-08-08 | Derivatives of 2-benzamido-5-nitro-thiazoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR201880A1 true AR201880A1 (es) | 1975-04-24 |
Family
ID=10397712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR255045A AR201880A1 (es) | 1973-08-08 | 1974-08-05 | Procedimiento para la preparacion de nuevos derivados de 2-benzamido-5-nitrotiazol |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US3950351A (es) |
| JP (1) | JPS5041858A (es) |
| AR (1) | AR201880A1 (es) |
| BE (1) | BE817878A (es) |
| CA (1) | CA1041519A (es) |
| CH (1) | CH583215A5 (es) |
| DE (1) | DE2438037C2 (es) |
| ES (1) | ES428906A1 (es) |
| FR (1) | FR2240010B1 (es) |
| GB (1) | GB1437800A (es) |
| IL (1) | IL45194A (es) |
| NL (1) | NL176779C (es) |
| OA (1) | OA04761A (es) |
| ZA (1) | ZA744409B (es) |
Families Citing this family (75)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2435905A1 (fr) * | 1978-09-13 | 1980-04-11 | Anvar | Nouveaux agents molluscicides derives du benzamido-2 nitro-5 thiazole |
| US4315018A (en) * | 1978-12-07 | 1982-02-09 | Rossignol Jean F | Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives |
| PH16300A (en) * | 1979-12-21 | 1983-09-05 | Wellcome Found | Notrothiazoline derivatives and their use as schistosonicidal agents |
| US5387598A (en) * | 1994-04-13 | 1995-02-07 | Rossignol; Jean-Francois | Composition and galenic formulation suitable for combatting affections of the lower abdomen |
| US5578621A (en) * | 1994-09-08 | 1996-11-26 | Romark Lab Lc | Benzamide derivatives |
| SI0755386T1 (en) * | 1994-04-13 | 2002-10-31 | Romark Laboratories, L.C. | Benzamide derivative, compositions containing said derivative and use thereof |
| US5968961A (en) * | 1997-05-07 | 1999-10-19 | Romark Laboratories, L.C. | Pharmaceutical compositions of tizoxanide and nitazoxanide |
| MX9604483A (es) * | 1994-09-08 | 1998-02-28 | Jean-Francois Rossignol | Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas. |
| US5859038A (en) * | 1994-09-08 | 1999-01-12 | Romark Laboratories, L.C. | Method for treatment of helicobacter pylori infections |
| SI20149B (en) * | 1997-05-07 | 2001-08-31 | Romark Lab Lc | Pharmaceutical compositions of tizoxanide and nitazoxanide |
| AU756451B2 (en) * | 1997-05-07 | 2003-01-16 | Romark Laboratories, L.C. | Pharmaceutical compositions of tizoxanide and nitazoxanide |
| US5935591A (en) * | 1998-01-15 | 1999-08-10 | Romark Laboratories, L.C. | Method for treatment of equine protozoal myeloencephalitis with thiazolides |
| US5925622A (en) * | 1998-07-13 | 1999-07-20 | Romark Laboratories, L.C. | Synthesis of aryl glucuronide of 2-hydroxy-N- (5-nitro-2-thiazolyl) benzamide, and pharmaceutical compositions comprising same |
| SE0102764D0 (sv) * | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
| US7125568B2 (en) * | 2001-08-23 | 2006-10-24 | Sung Michael T | Lipophilic drug compositions |
| GB0226930D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
| GB0325402D0 (en) * | 2003-10-31 | 2003-12-03 | Astrazeneca Ab | Compounds |
| GB0327761D0 (en) * | 2003-11-29 | 2003-12-31 | Astrazeneca Ab | Compounds |
| GB0328178D0 (en) * | 2003-12-05 | 2004-01-07 | Astrazeneca Ab | Compounds |
| JP2007523905A (ja) * | 2004-02-18 | 2007-08-23 | アストラゼネカ アクチボラグ | 化合物 |
| EP2048137A1 (en) * | 2004-02-18 | 2009-04-15 | AstraZeneca AB | Benzamide derivatives and their use as glucokinase activating agents. |
| TW200600086A (en) * | 2004-06-05 | 2006-01-01 | Astrazeneca Ab | Chemical compound |
| UA90864C2 (en) * | 2004-09-09 | 2010-06-10 | Ромарк Лебораториз, Л.К. | Halogenated benzamide derivatives |
| US20060194853A1 (en) * | 2004-10-08 | 2006-08-31 | Rossignol Jean F | Alkyl benzamides |
| GB0423044D0 (en) * | 2004-10-16 | 2004-11-17 | Astrazeneca Ab | Compounds |
| GB0423043D0 (en) * | 2004-10-16 | 2004-11-17 | Astrazeneca Ab | Compounds |
| BRPI0516595A (pt) | 2004-10-16 | 2008-09-23 | Astrazeneca Ab | processo para fabricar um composto, e, composto |
| AU2006235490A1 (en) * | 2005-04-12 | 2006-10-19 | Romark Laboratories, L.C. | Methods for treating diseases through the function of molecular chaperones such as protein disulfide isomerases, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents |
| EP1891069A1 (en) * | 2005-05-24 | 2008-02-27 | AstraZeneca AB | 2-phenyl substituted imidazol [4,5b]pyridine/ pyrazine and purine derivatives as glucokinase modulators |
| TW200714597A (en) * | 2005-05-27 | 2007-04-16 | Astrazeneca Ab | Chemical compounds |
| KR20110084339A (ko) * | 2005-07-09 | 2011-07-21 | 아스트라제네카 아베 | 당뇨병 치료에 있어 ｇｌｋ 활성화제로서 사용하기 위한 헤테로아릴 벤즈아미드 유도체 |
| EP2027113A1 (en) * | 2005-07-09 | 2009-02-25 | AstraZeneca AB | Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| US20110053910A1 (en) * | 2005-07-09 | 2011-03-03 | Mckerrecher Darren | 2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes |
| US9202182B2 (en) * | 2005-08-11 | 2015-12-01 | International Business Machines Corporation | Method and system for analyzing business architecture |
| TW200738621A (en) * | 2005-11-28 | 2007-10-16 | Astrazeneca Ab | Chemical process |
| MX2008008723A (es) * | 2006-01-09 | 2008-09-26 | Romark Lab Lc | Tratamiento de la hepatitis viral. |
| US7678791B2 (en) * | 2006-07-12 | 2010-03-16 | Cumbre Ip Ventures, L.P. | Nitroheteroaryl-containing rifamycin derivatives |
| CN100465169C (zh) * | 2006-08-02 | 2009-03-04 | 杭州欣阳三友精细化工有限公司 | 硝唑尼特的制备方法 |
| TW200825063A (en) * | 2006-10-23 | 2008-06-16 | Astrazeneca Ab | Chemical compounds |
| TW200825060A (en) * | 2006-10-26 | 2008-06-16 | Astrazeneca Ab | Chemical compounds |
| MX2009006729A (es) * | 2006-12-21 | 2009-08-07 | Astrazeneca Ab | Nuevo compuesto cristalino util como activador de glk. |
| CN101007792B (zh) * | 2007-01-31 | 2010-05-26 | 浙江大学 | 一种合成硝基噻唑苯酰胺化合物的方法 |
| EP2178852B9 (en) | 2007-08-03 | 2016-06-22 | Romark Laboratories, L.C. | Alkylsulfonyl-substituted thiazolide compounds |
| MX2011001333A (es) * | 2008-08-04 | 2011-03-15 | Astrazeneca Ab | Derivados de pirazolo [3, 4] pirimidin-4-ilo y sus usos para tratar la diabetes y obesidad. |
| UY32306A (es) | 2008-12-09 | 2010-07-30 | Gilead Sciences Inc | Derivados de pteridinona y pirimidinodiazepinona y composiciones farmacéuticas que modulan en forma selectiva los receptores tipo toll, métodos y usos |
| GB0902406D0 (en) * | 2009-02-13 | 2009-04-01 | Astrazeneca Ab | Crystalline polymorphic form |
| GB0902434D0 (en) * | 2009-02-13 | 2009-04-01 | Astrazeneca Ab | Chemical process |
| MX381895B (es) | 2009-02-13 | 2025-03-13 | Romark Laboratories Lc | Formulaciones farmaceuticas de liberacion controlada de nitazoxanida. |
| AR076220A1 (es) | 2009-04-09 | 2011-05-26 | Astrazeneca Ab | Derivados de pirazol [4,5 - e] pirimidina |
| WO2010116176A1 (en) * | 2009-04-09 | 2010-10-14 | Astrazeneca Ab | Pyrazolo [4, 5-e] pyrimidine derivative and its use to treat diabetes and obesity |
| CN105853415A (zh) | 2009-05-12 | 2016-08-17 | 罗马克实验室有限公司 | 卤代烷基杂芳基苯甲酰胺化合物 |
| BRPI1014322A2 (pt) | 2009-06-26 | 2015-08-25 | Romark Lab Lc | Método para tratar infecção, e para interromper ou evitar a produção de partículas virais infecciosas, combinação, e, composição farmacêutica. |
| CN101602744B (zh) * | 2009-06-30 | 2011-06-01 | 青岛康地恩药业有限公司 | 一种硝唑尼特的制备方法 |
| US9498441B2 (en) | 2012-01-27 | 2016-11-22 | Siegfried Rhein S.A. De C.V. | Nitazoxadine composition and process to prepare same |
| US20150250765A1 (en) | 2012-09-27 | 2015-09-10 | Siegfried Rhein S.A. De C.V. | Nitazoxanide and mebendazole synergic composition, processes for the preparation thereof, and use of said composition for the treatment of human parasitosis |
| US20160244435A1 (en) * | 2013-06-21 | 2016-08-25 | The Scripps Research Institute | Expanded therapeutic potential in nitroheteroaryl antimicrobials |
| SI3166607T1 (sl) | 2014-07-11 | 2023-01-31 | Gilead Sciences, Inc. | Modulatorji toličnih receptorjev za zdravljenje HIV-a |
| CN110305133A (zh) | 2014-09-16 | 2019-10-08 | 吉利德科学公司 | Toll样受体调节剂的固体形式 |
| JP6633092B2 (ja) | 2014-11-11 | 2020-01-22 | ロマーク ラボラトリーズ，リミティド カンパニー | チゾキサニド、その類似体又は塩のプロドラッグを用いる組成物及び治療方法 |
| CN105175352A (zh) * | 2015-10-27 | 2015-12-23 | 杭州澳医保灵药业有限公司 | 一种硝唑尼特的制备方法 |
| CN106831640A (zh) * | 2015-12-03 | 2017-06-13 | 江苏正大丰海制药有限公司 | 一种硝唑尼特晶体的制备方法 |
| HK1250945A1 (zh) | 2016-03-31 | 2019-01-18 | 罗马克实验室有限公司 | 用於治疗病毒性感染的噻唑化物化合物 |
| SI3442580T1 (sl) | 2016-04-11 | 2021-01-29 | Genfit | Metode zdravljenja holestatičnih in fibrotičnih bolezni |
| EP3573614B1 (en) | 2017-01-27 | 2024-11-20 | Genfit | Pharmaceutical compositions for combination therapy |
| US11173149B2 (en) | 2017-04-18 | 2021-11-16 | Romark Laboratories L.C. | Inhibition of protein disulfide-isomerase A3 |
| WO2019241376A1 (en) | 2018-06-14 | 2019-12-19 | The Trustees Of Columbia University In The City Of New York | Treatment of cognitive disorders using nitazoxanide (ntz), nitazoxanide (ntz) analogs, and metabolites thereof |
| EP3952869A1 (en) | 2019-04-12 | 2022-02-16 | Genfit | Nitazoxanide and thiazolides for use in the treatment of diseases associated with oxidative stress |
| CN113924114A (zh) | 2019-05-22 | 2022-01-11 | 吉利德科学公司 | Tlr7调节化合物和hiv疫苗的组合 |
| JP7741800B2 (ja) | 2019-10-28 | 2025-09-18 | ジェンフィット | 抗酸化性質を有する併用療法 |
| JP2023537237A (ja) | 2020-07-20 | 2023-08-31 | ロマーク ラボラトリーズ，リミティド カンパニー | チゾキサニドおよび２－ヒドロキシ－ｎ－（５－クロロ－１，３－チアゾル－２－イル）ベンズアミド（ｒｍ－４８４８）とエタノールアミン、モルホリン、プロパノールアミン、ピペラジン、およびｎ－メチルピペラジンの結晶塩 |
| IL300801A (en) | 2020-08-24 | 2023-04-01 | Romark Laboratories Lc | Use of thiazolides against the corona virus |
| CN114044761B (zh) * | 2021-02-24 | 2022-05-17 | 成都贝诺科成生物科技有限公司 | 一种新的硝基噻唑衍生物及其应用 |
| WO2022218239A1 (zh) * | 2021-04-12 | 2022-10-20 | 杜心赟 | 新型噻唑类化合物及其制备方法和用途 |
| US20240417381A1 (en) | 2021-10-05 | 2024-12-19 | Council Of Scientific And Industrial Research An Indian Registered Body Incorporated | An improved process for the preparation of nitazoxanide and intermediates thereof |
| CN116898846B (zh) * | 2022-04-12 | 2025-10-24 | 成都贝诺科成生物科技有限公司 | 一种硝基噻唑衍生物在制备抑制幽门螺杆菌的抑菌剂中的用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2735798A (en) * | 1956-02-21 | Acyl amevo-nitrothiazole compositions | ||
| CA497537A (en) * | 1953-11-10 | H. Clark Joe | 2-substituted amino-5-nitrothiazoles | |
| US2829084A (en) * | 1958-04-01 | Certain alkyl-n | ||
| US2401522A (en) * | 1942-04-17 | 1946-06-04 | Firm Sandoz Ltd | Aromatic carboxylic acid amides and a process for their manufacture |
| GB577418A (en) * | 1942-04-17 | 1946-05-17 | Sandoz Ltd | Process for the preparation of amides of aromatic carboxylic acids |
| FR1306603A (fr) * | 1958-08-14 | 1962-10-19 | Innothera Lab Sa | Dérivés thiazoliques et leur procédé de préparation |
| US3475446A (en) * | 1967-06-27 | 1969-10-28 | Parke Davis & Co | N-(5-nitro-2-thiazolyl)-cycloalkanecarboxamides |
-
1973
- 1973-08-08 GB GB3760873A patent/GB1437800A/en not_active Expired
-
1974
- 1974-07-03 IL IL45194A patent/IL45194A/en unknown
- 1974-07-09 ZA ZA00744409A patent/ZA744409B/xx unknown
- 1974-07-10 NL NLAANVRAGE7409321,A patent/NL176779C/xx not_active IP Right Cessation
- 1974-07-19 BE BE146759A patent/BE817878A/xx not_active IP Right Cessation
- 1974-07-23 CA CA205,468A patent/CA1041519A/en not_active Expired
- 1974-07-23 JP JP49083868A patent/JPS5041858A/ja active Pending
- 1974-08-02 ES ES428906A patent/ES428906A1/es not_active Expired
- 1974-08-05 AR AR255045A patent/AR201880A1/es active
- 1974-08-07 CH CH1083074A patent/CH583215A5/xx not_active IP Right Cessation
- 1974-08-07 DE DE2438037A patent/DE2438037C2/de not_active Expired
- 1974-08-08 OA OA55271A patent/OA04761A/xx unknown
- 1974-08-08 FR FR7427525A patent/FR2240010B1/fr not_active Expired
- 1974-08-08 US US05/495,749 patent/US3950351A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ZA744409B (en) | 1975-07-30 |
| JPS5041858A (es) | 1975-04-16 |
| NL176779B (nl) | 1985-01-02 |
| NL7409321A (nl) | 1975-02-11 |
| CH583215A5 (es) | 1976-12-31 |
| IL45194A0 (en) | 1974-10-22 |
| IL45194A (en) | 1977-10-31 |
| US3950351A (en) | 1976-04-13 |
| BE817878A (fr) | 1975-01-20 |
| OA04761A (fr) | 1980-08-31 |
| AU7135574A (en) | 1976-01-22 |
| GB1437800A (en) | 1976-06-03 |
| ES428906A1 (es) | 1976-08-16 |
| DE2438037A1 (de) | 1975-02-20 |
| CA1041519A (en) | 1978-10-31 |
| DE2438037C2 (de) | 1982-06-09 |
| FR2240010B1 (es) | 1978-03-24 |
| NL176779C (nl) | 1985-06-03 |
| FR2240010A1 (es) | 1975-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR207133A1 (es) | Procedimiento para la elaboracion de derivados de 1-piridiloxi 1-pirimidiniloxi y 1-piraziniloxi-2-hidroxi-3-amino-propano | |
| MX152550A (es) | Procedimiento para la preparacion de derivados de fenilnonatetraenos substituidos | |
| AR202617A1 (es) | Procedimiento para la preparacion de metitioetilclanoguanidinas heterociclicas | |
| MX4592E (es) | Procedimiento para la preparacion de 1-ariloxi-2-hidroxi-3-alquinilaminopropanos | |
| AR210725A1 (es) | Procedimiento para la preparacion de derivados de dibenzoxepina | |
| MX3765E (es) | Procedimiento para la preparacion de derivados de piperidina | |
| MX5768E (es) | Procedimiento para la preparacion de derivados del alpha-etil-benzhidrol | |
| AR203188A1 (es) | Procedimiento para la preparacion de derivados de tienotriazolodiacepina | |
| AR203653A1 (es) | Procedimiento para la obtencion de derivados de 3,4-dihidro-2h-naftalinona-(1)-5-oxi-propil-piperazina | |
| AR207022A1 (es) | Procedimiento para la preparacion de poli-n-dimetiliminoalano | |
| AR207744A1 (es) | Procedimiento para la preparacion de nuevos derivados de isotiocianopiridinas | |
| AR206632A1 (es) | Procedimiento para la preparacion de d-homoesteroides | |
| AR208187A1 (es) | Metodo para la preparacion derivados de n-carbamoil-2-feniletensulfonamida | |
| AR203196A1 (es) | Procedimiento para la preparacion de derivados de imidazol-5-carboxamidoxima | |
| AR205800A1 (es) | Procedimiento para la preparacion de nuevos derivados de 3,4-difenil-imidazolina | |
| AR200441A1 (es) | Procedimiento para la obtencion de nuevos derivados de alfa-l-arabinosido de digitoxigenina | |
| AR207633Q (es) | Procedimiento para la elaboracion de nuevos derivados de 2-benzoil-3-amino-6-cloro-piridinas | |
| AR210133A1 (es) | Procedimiento para preparar nuevos derivados de 3-amino-5-metil-pirrol | |
| AR207450A1 (es) | Procedimiento para la produccion de derivados de 4-fenilsulfonil-metil-prehidroindan-5-onas | |
| AR206653A1 (es) | Procedimiento para preparar nuevos derivados de n-aminoalquil-2-amino-indano | |
| AR209616A1 (es) | Procedimiento para la preparacion de derivados de 17alpha-aciloxi-d-homo-pregn-4-eno-3,20-diona | |
| AR211695A1 (es) | Procedimiento para la preparacion de derivados de aminoscilanilidas primarias | |
| AR202848A1 (es) | Procedimiento para la preparacion de derivados de triazolobenzodiacepinas | |
| AR201032A1 (es) | Un procedimiento para la preparacion de derivados de 5-feniltienodiazepinona | |
| ES550171A0 (es) | Procedimiento para la preparacion de espiramicina microen- capsulada |